文献速递高血压血脂与心血管预防

北京东城区社区卫生服务中心降压药处方及合理性分析

[Analysis of prescription and rationality of anti-hypertensive medication among community health centers in Beijing].
PubMed 文献 · Zhonghua Xin Xue Guan Bing Za Zhi · 2021-01-01

药物选择基本遵循指南,但联合用药欠合理、部分药物用量过大及「4+7」方案落实不完全是主要问题。

要点

  • CCB在各合并症高血压处方中开具最多,α受体拮抗剂最少。
  • 合并心衰者利尿剂占比21.17%,合并冠心病者BB占比更高。
  • 单一用药处方占61.19%,二联中CCB基础方案占66.36%。

核心结论

  • 基层降压药物种类多样且选择基本合理,但联合用药欠合理、用药过量及「4+7」方案未完全落实的问题较突出。

研究设计与样本

  • 横断面研究,分析2019年北京市东城区8家社区卫生服务中心的高血压处方。
  • 采用ATC编码分类药物,DDD法分析用量,DUI>1判定为过量。

主要发现

  • CCB在各合并症高血压处方中开具数量最多,α-肾上腺素受体拮抗剂最少。
  • 合并心衰者利尿剂占比21.17%(505/2 385),远高于其他合并症(P<0.05)。
  • 合并血脂异常者利尿剂占比低于其他合并症(P<0.05),BB和ARB更常被选择(BB 21.08%,ARB 18.24%)。
  • 合并慢性肾脏病者BB占比低于其他合并症(P<0.05),ARB和复方制剂占比较高(P<0.05)。
  • 合并冠心病者BB占比高于其他合并症(P<0.05);合并房颤或卒中者CCB占比较高(P<0.05)。

关键数值与推荐

  • DUI>1判定为用药过量。
  • 「4+7」方案药物共7种(氨氯地平、厄贝沙坦、氯沙坦、依那普利、福辛普利、赖诺普利、厄贝沙坦氢氯噻嗪),处方109 227张(16.60%),占所有可能方案的40.92%(109 227/266 993)。

临床怎么用

  • 基层处方总体遵循指南,但需重点关注联合用药方案的合理性。
  • 应监测DUI>1的药物,避免用量过量。
  • 促进「4+7」方案药物在基层的落实。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: Explore the usage of anti-hypertension drugs and the rationality of hypertension prescription among the primary health centers in Dongcheng District, Beijing. Method: This cross-sectional and retrospective study was applied to analyze the hypertension prescriptions from the 8 community health centers in Dongcheng District. The anatomical, therapeutic and chemical classification (ATC) codes were used to determine the drug category. ATC information was used to filter data containing antihypertensive drugs, and group the number and proportion of ATC categories. The type of drug was judged by its generic name. According to the diagnosis information in the prescription, the prescription containing the Western medicine diagnosis of hypertension was screened out. The comorbidities of hypertension in the study included 7 types of diseases including diabetes, chronic kidney disease, coronary heart disease, heart failure, atrial fibrillation, stroke, and dyslipidemia. The analysis of prescription rationality included rationality of combination medication, rationality of drug dosage and rationality of drug price. The agreed daily dose (DDD) method was used to analyze the rationality of drug dosage. The drug utilization index (DUI) was used as a quantitative indicator to estimate the rationality of medication, and overdose was expressed by DUI>1. The reasonableness of the drug price was judged based on the price of the drug and whether it was a drug in the "4+7" plan. Results: A total of 658 140 prescriptions were extracted as the final data set, involving 7 categories and 60 commonly used anti-hypertensive drugs, and the corresponding cost of medication was ¥96.58 million. Drugs were prescribed according to comorbidities, and the choice followed the international guidelines. Calcium channel blockers (CCB) were the most prescribed drugs in the prescriptions of patients with comorbidities, and α-adrenergic receptor antagonists were the least prescribed drugs. The proportion of diuretics prescribed in hypertensive patients complicating with heart failure was 21.17% (505/2 385), which was much higher than that of patients complicating with other comorbidities (P<0.05). The proportion of diuretics prescribed in hypertension patients complicating with dyslipidemia was lower than that of patients with other comorbidities (2 639 (0.94%), P<0.05), and β-blockers (BB) or angiotensin Ⅱreceptor blockers (ARB) were more likely to be selected (BB: 59 348 (21.08%), ARB: 51 356 (18.24%))in these patients. The proportion of BB in prescriptions for hypertension patients with chronic kidney disease was lower than that of patients with other comorbidities (P<0.05). The proportion of BB in prescriptions for hypertension patients with coronary heart disease was higher than that of other comorbidities (P<0.05). Hypertension patients with atrial fibrillation or stroke accounted for a higher proportion of CCB prescriptions (P<0.05). Single antihypertensive drug prescriptions accounted for the highest proportion, 61.19% (402 745/658 140). Two-combination prescriptions accounted for the highest proportion of combination prescriptions, 72.19% (184 392/255 395). CCB based two-combination prescriptions accounted for the highest proportion, 122 350(66.36%). ARB-based tri-combination prescriptions accounted for the highest proportion, 48 915(89.50%),followed by CCB based tri-combination prescriptions (44 732(81.85%)).There were 2 174 (0.33%) prescriptions with unreasonable combination therapies and DUI>1 were found in 48 out of 60 commonly used drugs. In all possible antihypertensive drugs, only 40.92% (109 227/266 993)followed the "4+7" plan. Conclusions: The anti-hypertensive agents from these prescriptions in the primary health centers are diverse, and the choice is generally complied with the guidelines, but some unreasonable situations existed, especially on the combined anti-hypertensive medication, overdose, and"4+7"plan is not followed completely. 目的: 调查北京市东城区基层医疗卫生机构降压药物的使用情况并分析其合理性。 方法: 该研究为横断面调查。对2019年1月1日至12月31日北京市东城区8家社区卫生服务中心的降压药物处方进行分析。以解剖学、治疗学及化学分类系统(ATC)编码判断药物类别。使用ATC信息对包含降压药物的数据进行筛选,并按ATC类别分组统计数量和占比。由通用名判断药物品种。依据处方中的诊断信息筛选出包含高血压西医诊断的处方。该研究中高血压合并症包括糖尿病、慢性肾脏病、冠心病、心力衰竭、心房颤动、卒中和血脂异常7种。处方合理性分析包括联合用药合理性、药物用量合理性和药物价格合理性。采用约定日剂量(DDD)法来分析药物用量合理性。将药物利用指数(DUI)作为估计用药合理性的定量指标,DUI>1判定为用药过量。药物价格合理性基于药品的价格和是否为“4+7”方案中的药物进行判断。 结果: 共筛选出658 140张包含高血压诊断及降压药物的处方,销售总金额为9 658.11万元人民币,涉及7类、60种常用降压药物。钙通道阻滞剂(CCB)在各合并症高血压患者的处方中开具的数量均为最多,α-肾上腺素受体拮抗剂最少。合并心力衰竭的高血压患者处方中利尿剂的占比为21.17%(505/2 385),远高于其他合并症的患者(P均<0.05)。合并血脂异常的高血压患者处方中利尿剂的占比则低于其他合并症的患者(P均<0.05),而β-受体阻滞剂(BB)或血管紧张素Ⅱ受体阻滞剂(ARB)更易被选择[BB为59 348(21.08%),ARB为51 356(18.24%)]。合并慢性肾脏病的高血压患者处方中BB的占比低于其他合并症的患者(P均<0.05),但ARB和复方制剂的占比均较高(P均<0.05)。合并冠心病的高血压患者处方中BB的占比高于其他合并症(P均<0.05)。合并心房颤动或卒中的高血压患者处方中CCB的占比较高(P均<0.05)。单一降压药物处方数占比最高,为61.19%(402 745/658 140)。联合用药处方中二联用药处方占比最高,为72.19%(184 392/255 395)。在二联用药处方中,以CCB为基础的组合处方数最多,为122 350张(66.36%)。在三联用药处方中,以ARB为基础的组合处方数最多,为48 915张(89.50%),其次为CCB[44 732(81.85%)]。不合理联合用药的处方数为2 174张(0.33%)。60种降压药物中48种DUI>1。处方中共计出现7种“4+7”方案中的降压药物,分别为氨氯地平、厄贝沙坦、氯沙坦、依那普利、福辛普利、赖诺普利和厄贝沙坦氢氯噻嗪,总处方数为109 227张(16.60%),占所有可能“4+7”方案降压药物的40.92%(109 227/266 993)。 结论: 北京市东城区基层医疗卫生机构开具的降压药物种类众多、药物选择基本合理,但降压药物联合应用方案欠合理的问题较为突出,且存在用药过量以及“4+7”方案未完全落实的情况。.

来源:Zhonghua Xin Xue Guan Bing Za Zhi,查看原文。版权归原作者所有。

引用

  1. Bai JJ, Zhang WL, Wang L, et al. [Analysis of prescription and rationality of anti-hypertensive medication among community health centers in Beijing]. Zhonghua Xin Xue Guan Bing Za Zhi. 2021. PMID: 34674437. doi:10.3760/cma.j.cn112148-20201231-01022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。